Condensed Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Treasury Stock [Member]
Beginning balance at Dec. 31, 2017	$ 12,445,778	$ 1,114	$ 47,423,915	$ (34,972,787)	$ (6,464)
Beginning balance, shares at Dec. 31, 2017		11,139,667			808
Common stock issued upon vesting of restricted stock units	(63,149)	$ 3	(63,152)
Common stock issued upon vesting of restricted stock units, Shares		31,152
Common stock issued for the exercise of warrants	$ 3,550,490	$ 120	3,550,370
Common stock issued for the exercise of warrants, shares		1,203,556
Restricted stock vested		$ 3	(3)
Restricted stock vested, shares	17,570	32,540
Stock-based compensation	$ 336,355		336,355
Net loss	(2,345,402)			(2,345,402)
Ending balance at Mar. 31, 2018	13,924,072	$ 1,240	51,247,485	(37,318,189)	$ (6,464)
Ending balance, shares at Mar. 31, 2018		12,406,915			808
Beginning balance at Dec. 31, 2018	6,425,885	$ 1,245	51,720,630	(45,289,526)	$ (6,464)
Beginning balance, shares at Dec. 31, 2018		12,450,187			808
Cumulative impact of ASC 606	(123,447)			(123,447)
Proceeds of public offering, net offering costs of $710,572	5,648,928	$ 454	5,648,474
Proceeds from offering costs, shares		4,542,500
Common stock issued upon vesting of restricted stock units	144,556	$ 10	144,546
Common stock issued upon vesting of restricted stock units, Shares		95,001
Restricted stock vested	$ 11,961	$ 1	11,960
Restricted stock vested, shares	45,459	10,436
Fair value of warrants issued recorded as a derivative liability	$ (196,236)		(196,236)
Stock-based compensation	207,605		207,605
Net loss	(2,598,060)			(2,598,060)
Ending balance at Mar. 31, 2019	$ 9,521,192	$ 1,710	$ 57,536,979	$ (48,011,033)	$ (6,464)
Ending balance, shares at Mar. 31, 2019		17,098,124			808